Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t20:0/26:0)

Term ID

CHEBI:60444

Synonyms

(2S,3S)-2-(hexacosanoylamino)-3,4-dihydroxyicosyl (1R,2R,3R,4R,5S,6R)-2,3,4,5-tetrahydroxy-6-{[6-O-(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)-D-mannopyranosyl]oxy}cyclohexyl hydrogen phosphate
1D-6-O-{[6-O-(hydroxy{[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)-D-mannopyranosyl]}-myo-inositol 1-[(2S,3S)-2-(hexacosanoylamino)-3,4-dihydroxyicosyl hydrogen phosphate]
inositol phosphomannosylinositol phosphoceramide B (20:0/26:0)
inositol phosphomannosylinositol phosphoceramide B (C26)
M(IP)2C-2 (C26)
M(IP)2C-B (C26)

Definition

An inositol phosphomannosylinositol phosphoceramide compound having a hexacosanoyl group attached to the ceramide nitrogen, hydroxylation at C-4 of the long-chain base, and no additional hydroxylation of the very-long-chain fatty acid.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: inositol phosphomannosylinositol phosphophytoceramide

inositol phosphomannosylinositol phosphophytoceramide Show first 5 Terms
has_functional_parent: Man-beta1-6-Ins-1-P-Cer(t20:0/26:0)

Man-beta1-6-Ins-1-P-Cer(t20:0/26:0) Show first 5 Terms

Phenotype

Phenotype resulting from Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t20:0/26:0)

Phenotype where environments contain Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t20:0/26:0)

Phenotype modified by environments containing Ins-1-P-6-Man-beta1-6-Ins-1-P-Cer(t20:0/26:0)

Human Disease Model